Neurocrine

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Neurocrine and other ETFs, options, and stocks.

About NBIX

Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company, which engages in the research and development, commercialization, and sale of pharmaceuticals for the treatment of neurological, neuroendocrine, and neuropsychiatric disorders. Its portfolio of products includes treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia (CAH), and endometriosis and uterine fibroids.

CEO

Kyle W. Gano

CEOKyle W. Gano

Employees

1,800

Employees1,800

Headquarters

San Diego, California

HeadquartersSan Diego, California

Founded

1992

Founded1992

Employees

1,800

Employees1,800

NBIX Key Statistics

Market cap

12.48B

Market cap12.48B

Price-Earnings ratio

42.24

Price-Earnings ratio42.24

Dividend yield

—

Dividend yield—

Average volume

1.13M

Average volume1.13M

High today

$126.22

High today$126.22

Low today

$123.53

Low today$123.53

Open price

$124.44

Open price$124.44

Volume

416.60K

Volume416.60K

52 Week high

$157.98

52 Week high$157.98

52 Week low

$84.23

52 Week low$84.23

Analyst ratings

85%

of 27 ratings

Buy

85.2%

Hold

14.8%

Sell

People also own

Based on the portfolios of people who own NBIX. This list is generated using Robinhood data, and it’s not a recommendation.

CrowdStrike Holdings

Trade Desk

Shopify

Take-Two Interactive Soft…

Disney

Fiverr International